Literature DB >> 1717289

In vivo persistence of a HIV-1-encoded HLA-B27-restricted cytotoxic T lymphocyte epitope despite specific in vitro reactivity.

A Meyerhans1, G Dadaglio, J P Vartanian, P Langlade-Demoyen, R Frank, B Asjö, F Plata, S Wain-Hobson.   

Abstract

A large number of human immunodeficiency virus type 1 (HIV-1) specific HLA-restricted cytotoxic T cell (CTL) epitopes have been mapped, including an HLA-B27-restricted immunodominant epitope within p25gag. Accordingly, this segment of the HIV-1 provirus was amplified by the polymerase chain reaction from DNA derived from fresh uncultured peripheral blood mononuclear cells (PBMC) of four HLA-B27 HIV-1-infected individuals. In all cases the majority of infected PBMC bore sequences encoding the HLA-B27-restricted peptide. CTL escape mutants had not accumulated in vivo 8 and 14 months later despite demonstrable CTL activity in vitro. These data emphasize the importance of silently infected lymphocytes in evading immune surveillance.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1717289     DOI: 10.1002/eji.1830211051

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  29 in total

1.  How cytotoxic T cells manage to discriminate nonself from self at the nonapeptide level.

Authors:  S Ohno
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-15       Impact factor: 11.205

2.  Emergence of virus escape mutants after immunization with epitope vaccine.

Authors:  G Weidt; W Deppert; O Utermöhlen; J Heukeshoven; F Lehmann-Grube
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

3.  Genetic drift can dominate short-term human immunodeficiency virus type 1 nef quasispecies evolution in vivo.

Authors:  U Plikat; K Nieselt-Struwe; A Meyerhans
Journal:  J Virol       Date:  1997-06       Impact factor: 5.103

4.  Herpesvirus saimiri-transformed human CD4+ T-cell lines: an efficient target cell system for the analysis of human immunodeficiency virus-specific cytotoxic CD8+ T-lymphocyte activity.

Authors:  M Bauer; M Lucchiari-Hartz; H Fickenscher; K Eichmann; J McKeating; A Meyerhans
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

5.  Persistent hepatitis C virus infection in a chimpanzee is associated with emergence of a cytotoxic T lymphocyte escape variant.

Authors:  A Weiner; A L Erickson; J Kansopon; K Crawford; E Muchmore; A L Hughes; M Houghton; C M Walker
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

Review 6.  Pathogenesis of human immunodeficiency virus infection.

Authors:  J A Levy
Journal:  Microbiol Rev       Date:  1993-03

Review 7.  HIV-1 proteins in infected cells determine the presentation of viral peptides by HLA class I and class II molecules and the nature of the cellular and humoral antiviral immune responses--a review.

Authors:  Y Becker
Journal:  Virus Genes       Date:  1994-07       Impact factor: 2.332

8.  Lack of strong immune selection pressure by the immunodominant, HLA-A*0201-restricted cytotoxic T lymphocyte response in chronic human immunodeficiency virus-1 infection.

Authors:  C Brander; K E Hartman; A K Trocha; N G Jones; R P Johnson; B Korber; P Wentworth; S P Buchbinder; S Wolinsky; B D Walker; S A Kalams
Journal:  J Clin Invest       Date:  1998-06-01       Impact factor: 14.808

9.  Evolution of human immunodeficiency virus type 1 cytotoxic T-lymphocyte epitopes: fitness-balanced escape.

Authors:  Yi Liu; John McNevin; Hong Zhao; Denis M Tebit; Ryan M Troyer; Matthew McSweyn; Ananta K Ghosh; Daniel Shriner; Eric J Arts; M Juliana McElrath; James I Mullins
Journal:  J Virol       Date:  2007-08-29       Impact factor: 5.103

10.  The differential ability of HLA B*5701+ long-term nonprogressors and progressors to restrict human immunodeficiency virus replication is not caused by loss of recognition of autologous viral gag sequences.

Authors:  Stephen A Migueles; Alisha C Laborico; Hiromi Imamichi; W Lesley Shupert; Cassandra Royce; Mary McLaughlin; Linda Ehler; Julia Metcalf; Shuying Liu; Claire W Hallahan; Mark Connors
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.